SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

AGM Statement

5 Sep 2018 14:56

RNS Number : 8946Z
British Smaller Companies VCT PLC
05 September 2018
Β 

BRITISH SMALLER COMPANIES VCT PLC

RESULT OF ANNUAL GENERAL MEETING

British Smaller Companies VCT plc (the "Company") announces that at the Annual General Meeting of the Company held on 5 September 2018 the following resolutions proposed at the meeting ("Resolutions") were duly passed.

Β 

In accordance with the Company's obligations under Listing Rule 9.6.2, copies of the Resolutions passed at the Annual General Meeting will be submitted to the National Storage Mechanism and will shortly be available for viewing at www.hemscott.com/nsm.do.

Β 

Ordinary Resolutions

Β 

(1) That the annual report and accounts for the year ended 31 March 2018 be received.

Β 

(2) That the Directors' Remuneration Report for the year ended 31 March 2018 be approved other than the part of such report containing the Directors' Remuneration Policy.

Β 

(3) That Ms H Sinclair be re-elected as a director.

Β 

(4) That Mr C W E R Buchan be re-elected as a director.

Β 

(5) That Mr R W Cook be re-elected as a director.

Β 

(6) That BDO LLP be re-appointed as auditor to the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and that the directors be authorised to fix their remuneration.

Β 

(7) That the directors be and are hereby generally and unconditionally authorised in accordance with Section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of Β£5,000,000, during the period commencing on the passing of this Resolution and expiring on the later of 15 months from the passing of this Resolution or the next Annual General Meeting of the Company (unless previously revoked, varied or extended by the Company in general meeting), but so that this authority shall allow the Company to make before the expiry of this authority offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for or to convert any security into shares to be granted, after such expiry and that all previous authorities given to the directors be and they are hereby revoked, provided that such revocation shall not have retrospective effect.

Β 

(8) That the directors be and are hereby generally and unconditionally authorised in accordance with section 551 of the Act to exercise all the powers of the Company to allot shares in the Company in connection with the dividend re-investment scheme up to an aggregate nominal amount of Β£1,500,000 representing approximately 14 per cent of the share capital in issue as at 26 June 2018 (excluding treasury shares) during the period commencing on the date of this resolution and expiring on the fifth anniversary of this resolution (unless previously revoked, varied or extended by the Company in general meeting) but so that this authority shall allow the Company to make before the expiry of this authority offers or agreements which would or might require shares to be allotted after such expiry and that all previous authorities given to the directors to allot shares in connection with the dividend reinvestment scheme be and they are hereby revoked, provided that such revocation shall not have retrospective effect.

Β 

Β 

Β 

Special Resolutions

Β 

(9) That the directors be and are hereby empowered in accordance with Section 570(1) of the Act during the period commencing on the passing of this Resolution and expiring at the conclusion of the Company's next Annual General Meeting, or on the expiry of 15 months following the passing of this Resolution, whichever is the later, (unless previously revoked, varied or extended by the Company in general meeting), to allot equity securities (as defined in Section 560 of the Act) for cash pursuant to the general authority conferred upon the directors in Resolution 7 above as if Section 561 of the Act did not apply to any such allotment provided that this power is limited to the allotment of equity securities in connection with the allotment for cash of equity securities up to an aggregate nominal amount of Β£5,000,000, but so that this authority shall allow the Company to make offers or agreements before the expiry and the directors may allot securities in pursuance of such offers or agreements as if the powers conferred hereby had not so expired. This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of Section 560(3) of the Act (treasury shares) as if in the first paragraph of this Resolution the words "pursuant to the general authority conferred upon the directors in Resolution 7 above" were omitted.

Β 

(10) That the directors be and are hereby empowered in accordance with section 570 of the Act during the period commencing on the passing of this resolution and expiring on the fifth anniversary of this resolution (unless previously revoked, varied or extended by the Company in general meeting), to allot equity securities (as defined in section 560 of the Act) for cash pursuant to the general authority conferred upon the directors in Resolution 8 above as if section 561 of the Act did not apply to any such allotment provided that this power is limited to the allotment of equity securities in connection with the dividend re-investment scheme up to an aggregate nominal amount of Β£1,500,000, representing approximately 14 per cent of the issued share capital of the Company as at 26 June 2018 (excluding treasury shares) but so that this authority shall allow the Company to make offers or agreements before the expiry and the directors may allot equity securities in pursuance of such offers or agreements as if the powers conferred hereby had not so expired.

Β 

Proxy votes received were:

Β 

Resolution

%

For and Discretion

Β 

% Against

Β 

Shares Withheld

Ordinary Resolutions

Β 

Β 

Β 

1.

To receive the annual report and accounts

100.00

-

5,424

2.

To approve the Directors' Remuneration Report

95.71

4.29

183,526

3.

To re-elect Ms H Sinclair as a director

97.43

2.57

101,974

4.

To re-elect Mr C W E R Buchan as a director

98.77

1.23

99,440

5.

To re-elect Mr R W Cook as a director

98.79

1.21

66,257

6.

To re-appoint BDO LLP as auditor

98.48

1.52

119,593

7.

To authorise the directors to allot shares

98.45

1.55

5,934

8.

To authorise the directors to allot shares pursuant to the DRIS

99.08

0.92

34,968

Special Resolutions

Β 

Β 

Β 

9.

To waive pre-emption rights in respect of the allotment of shares and allow treasury shares to be reissued

93.05

6.95

52,232

10.

To waive pre-emption rights in respect of the allotment of shares pursuant to the DRIS

96.97

3.03

64,997

Β 

5 September 2018

For further information, please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 866 2715

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
AGMSSIFDIFASEIU
Date   Source Headline
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report
4th Nov 20228:30 amRNSDividend Declaration
24th Oct 20229:00 amRNSChange of Registrar
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 202212:25 pmRNSDirector/PDMR Shareholding
3rd Oct 202212:20 pmRNSPayment of Dividend and Issue of Equity
28th Sep 202211:13 amRNSTransaction in Own Shares
20th Sep 20229:30 amRNS1st Quarter Results
16th Sep 202211:42 amRNSResult of AGM
4th Aug 202211:45 amRNSDividend Declaration
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
12th Jul 202211:30 amRNSDirector/PDMR Shareholding
12th Jul 202211:30 amRNSDirector/PDMR Shareholding
12th Jul 202211:30 amRNSPayment of Dividend and Allotment of Shares
29th Jun 202210:00 amRNSPurchase of Own Securities and Net Asset Value
21st Jun 20223:00 pmRNSAnnual Financial Report
6th Jun 20227:58 amRNSDirectorate Change
31st May 20227:00 amRNSDividend Declaration
5th Apr 20228:33 amRNSDirector Declaration
30th Mar 20227:56 amRNSTransaction in Own Shares
21st Mar 20221:15 pmRNS3rd Quarter Results
1st Mar 20228:18 amRNSDirector Declaration
1st Feb 20228:30 amRNSDirector Declaration
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSIssue of Equity and Close of Offers
5th Jan 202210:21 amRNSDirector/PDMR Shareholding
5th Jan 202210:20 amRNSPayment of interim dividend and issue of shares
16th Dec 20219:55 amRNSTransaction in Own Shares
6th Dec 202110:37 amRNSPublication of Supplementary Prospectus
6th Dec 202110:33 amRNSPublication of Supplementary Prospectus
18th Nov 20218:08 amRNSHalf-year Report
16th Nov 202110:08 amRNSDirector/PDMR Shareholding
16th Nov 202110:08 amRNSPayment of dividend and allotment of shares
12th Nov 20217:00 amRNSClose of Offers to New Applications
12th Nov 20217:00 amRNSClose of Offers to New Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.